Ftse Mib
35.398,82
-0,03%
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
NASDAQ
16.685,97
-0,07%
Bitcoin
66.952,86
-0,19%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ PainReform Ltd (PRFX) PainReform Ltd (PRFX) Notizie

PRFX

PainReform (PRFX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PRFX
DataOraFonteTitoloSimboloCompagnia
15/05/202422:05GlobeNewswire Inc.PainReform Provides Business Update for the First Quarter of 2024NASDAQ:PRFXPainReform Ltd
08/05/202414:30GlobeNewswire Inc.PainReform CEO Ilan Hadar Discusses Latest Developments Related to PRF-110 and its Potential to Help Tackle the Opioid Epidemic on Proactiveinvestors.comNASDAQ:PRFXPainReform Ltd
18/04/202420:19GlobeNewswire Inc.PainReform Announces Closing of $4 Million Public OfferingNASDAQ:PRFXPainReform Ltd
16/04/202414:00GlobeNewswire Inc.PainReform Announces Pricing of $4 Million Public OfferingNASDAQ:PRFXPainReform Ltd
09/04/202415:00GlobeNewswire Inc.PainReform’s Non-Opiate Topical Treatment for Post-Surgical Pain Relief Outperforms Leading Competitor Under Various Testing ConditionsNASDAQ:PRFXPainReform Ltd
02/04/202414:30GlobeNewswire Inc.PainReform Reaches 50% Enrollment in the Second Part of its Phase 3 Clinical Trial of PRF-110 in BunionectomyNASDAQ:PRFXPainReform Ltd
07/03/202423:25Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRFXPainReform Ltd
01/03/202422:34Edgar (US Regulatory)Form F-1 - Registration statement for certain foreign private issuersNASDAQ:PRFXPainReform Ltd
01/03/202414:00GlobeNewswire Inc.PainReform Provides Year-End Business UpdateNASDAQ:PRFXPainReform Ltd
29/02/202422:37Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:PRFXPainReform Ltd
22/01/202414:30GlobeNewswire Inc.PainReform to Present at the Microcap Conference in Atlantic CityNASDAQ:PRFXPainReform Ltd
22/01/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PRFXPainReform Ltd
19/01/202422:30Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PRFXPainReform Ltd
12/01/202422:15Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:PRFXPainReform Ltd
03/01/202414:30GlobeNewswire Inc.PainReform Reports Successful Head-to-Head Comparison of PRF-110 Versus Market Leading Post Surgical Analgesia for Extended Postoperative Pain ReliefNASDAQ:PRFXPainReform Ltd
27/12/202300:00GlobeNewswire Inc.PainReform Announces Exercise of Warrants for Approximately $1.3 Million in Gross ProceedsNASDAQ:PRFXPainReform Ltd
15/11/202322:05GlobeNewswire Inc.PainReform Provides Business Update for the Third Quarter of 2023NASDAQ:PRFXPainReform Ltd
11/09/202314:30GlobeNewswire Inc.PainReform Announces Plans to Commence Second Part of Phase 3 Clinical Trial to Evaluate PRF-110 in Patients Undergoing Bunionectomy Surgery Following Positive FDA Review of Drug Master FileNASDAQ:PRFXPainReform Ltd
07/09/202316:00GlobeNewswire Inc.PainReform Selected for Poster Presentation at the 13th Congress of the European Pain Federation in Budapest, HungaryNASDAQ:PRFXPainReform Ltd
05/09/202314:30GlobeNewswire Inc.PainReform to Participate in the H.C. Wainwright 25th Annual Global Investment Conference in New York CityNASDAQ:PRFXPainReform Ltd
10/08/202322:05GlobeNewswire Inc.PainReform Provides Business Update for the Second Quarter of 2023NASDAQ:PRFXPainReform Ltd
19/07/202315:00GlobeNewswire Inc.PainReform Regains Compliance with Nasdaq Continued Listing RequirementsNASDAQ:PRFXPainReform Ltd
18/07/202317:59Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:PRFXPainReform Ltd
14/07/202320:35GlobeNewswire Inc.PainReform Announces Pricing of $1.5 Million Concurrent Registered Direct Offering and Private PlacementNASDAQ:PRFXPainReform Ltd
12/07/202315:05GlobeNewswire Inc.PainReform Announces Pricing of $2.7 Million Concurrent Registered Direct Offering and Private PlacementNASDAQ:PRFXPainReform Ltd
15/06/202314:30GlobeNewswire Inc.PainReform to Present at the Maxim Group Virtual Healthcare Conference Hosted by M-Vest on June 21stNASDAQ:PRFXPainReform Ltd
07/06/202322:30GlobeNewswire Inc.PainReform Provides Regulatory Update on Second Part of its Phase 3 Clinical Trial of PRF-110 in Patients Undergoing Bunionectomy SurgeryNASDAQ:PRFXPainReform Ltd
18/05/202315:11Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRFXPainReform Ltd
18/05/202315:00GlobeNewswire Inc.PainReform Announces Positive Pharmacokinetic (PK) Data in First Part of Phase 3 Clinical Trial of PRF-110 in Patients Undergoing Bunionectomy SurgeryNASDAQ:PRFXPainReform Ltd
15/05/202322:45GlobeNewswire Inc.PainReform Provides Business Update for the First Quarter of 2023NASDAQ:PRFXPainReform Ltd
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PRFX

La tua Cronologia

NASDAQ
FGBIP
First Guaranty Bancshares
LSE
RB31
Roy.bk.can 24
BIT
AL4095
Banca Aletti and C
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network